These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9794259)

  • 1. The aetiology of Raynaud's phenomenon.
    Turton EP; Kent PJ; Kester RC
    Cardiovasc Surg; 1998 Oct; 6(5):431-40. PubMed ID: 9794259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathology of Raynaud phenomenon: current data].
    Mourad JJ; Priollet P
    Rev Med Interne; 1997; 18(8):611-7. PubMed ID: 9365735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raynaud's phenomenon].
    Sprynger M
    Rev Med Liege; 2004 Jun; 59(6):378-84. PubMed ID: 15346976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon.
    Bunker CB; Goldsmith PC; Leslie TA; Hayes N; Foreman JC; Dowd PM
    Br J Dermatol; 1996 Mar; 134(3):399-406. PubMed ID: 8731660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital cutaneous vascular responses to histamine and neuropeptides in Raynaud's phenomenon.
    Bunker CB; Foreman JC; Dowd PM
    J Invest Dermatol; 1991 Mar; 96(3):314-7. PubMed ID: 2002251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: implications for vascular dysfunction and progression of disease.
    Rajagopalan S; Pfenninger D; Kehrer C; Chakrabarti A; Somers E; Pavlic R; Mukherjee D; Brook R; D'Alecy LG; Kaplan MJ
    Arthritis Rheum; 2003 Jul; 48(7):1992-2000. PubMed ID: 12847693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and neuropeptides in Raynaud's phenomenon.
    Generini S; Seibold JR; Matucci-Cerinic M
    Rheum Dis Clin North Am; 2005 Feb; 31(1):177-86, x-xi. PubMed ID: 15639062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's phenomenon.
    Wigley FM
    Curr Opin Rheumatol; 1993 Nov; 5(6):773-84. PubMed ID: 8117541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current pathophysiological views on vibration-induced Raynaud's phenomenon.
    Stoyneva Z; Lyapina M; Tzvetkov D; Vodenicharov E
    Cardiovasc Res; 2003 Mar; 57(3):615-24. PubMed ID: 12618223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients.
    Planchon B; Pistorius MA; Beurrier P; De Faucal P
    Angiology; 1994 Aug; 45(8):677-86. PubMed ID: 8048777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital blood flow response to body warming, cooling, and rewarming in patients with Raynaud's phenomenon.
    Lau CS; Khan F; Brown R; McCallum P; Belch JJ
    Angiology; 1995 Jan; 46(1):1-10. PubMed ID: 7818151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.
    Sunderkötter C; Riemekasten G
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Raynaud's phenomenon is associated with microvascular peripheral endothelial dysfunction.
    Taher R; Sara JD; Toya T; Shepherd R; Moder K; Lerman LO; Lerman A
    Microvasc Res; 2020 Nov; 132():104040. PubMed ID: 32768463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon: from molecular pathogenesis to therapy.
    Prete M; Fatone MC; Favoino E; Perosa F
    Autoimmun Rev; 2014 Jun; 13(6):655-67. PubMed ID: 24418302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.